ライフサイエンスコーパス: ECG monitor

1 ting in the morning with ambulatory one-lead ECG monitors.

2 thmia activity were assessed with telemetric ECG monitors.

3 with the standard practice of short-duration ECG monitoring.

4 tually demonstrate AF, such as on ambulatory ECG monitoring.

5 the modified V(5) position by 24-hour Holter ECG monitoring.

6 Patients underwent 48 h of ambulatory ECG monitoring.

7 e or frequency of ischemia during ambulatory ECG monitoring.

8 isode of ST-segment depression on ambulatory ECG monitoring.

9 electrophysiological study or by ambulatory ECG monitoring.

10 mptom-limited cycle ergometry during 12-lead ECG monitoring.

11 mented with continuous electrocardiographic (ECG) monitoring.

12 schemia who underwent 48 hours of ambulatory ECG monitoring, 58 patients exhibited ambulatory ischemi

13 ntitative 2D echocardiography and ambulatory ECG monitoring after myocardial infarction.

14 ot receiving beta-blockers during ambulatory ECG monitoring after surgery.

15 d at least 24 hours of electrocardiographic (ECG) monitoring after an ischemic stroke to rule out atr

16 artery disease patients underwent ambulatory ECG monitoring and completed a structured diary assessin

17 Ischemia end points, including ambulatory ECG monitoring and exercise treadmill testing, and endot

18 However, with appropriate ECG monitoring and management of electrolytes and concom

19 high (HF)-frequency heart rate variability, ECG monitoring, and the plasma markers von Willebrand fa

20 chemia on 48-h ambulatory electrocardiogram (ECG) monitoring, and resting and mental stress-induced l

21 Continuous 12-lead ECG monitoring can be an inexpensive and reliable modali

22 nts were on continuous electrocardiographic (ECG) monitoring during hospitalization and 12-lead ECG w

23 iac evaluation, including 24-hour ambulatory ECG monitoring, echocardiography, and exercise testing,

24 Online ECG monitoring education and strategies to change practi

25 e 2-part intervention consisted of an online ECG monitoring education program and strategies to imple

26 Each patient underwent continuous 12-lead ECG monitoring for 36 to 72 hours with the Mortara ST mo

27 Noninvasive ambulatory ECG monitoring for a target of 30 days significantly imp

28 We also performed ambulatory ECG monitoring for arrhythmias and heart rate variabilit

29 ICDs were interrogated and ambulatory ECGs monitored for NSVT episodes, with associations betw

30 uidelines for the care of patients receiving ECG monitoring has led clinicians to rely too heavily on

31 significantly reduced ischemia on continuous ECG monitoring (Holter) at 48 hours compared with placeb

32 iding care for patients receiving continuous ECG monitoring in non-critical care areas.

33 follow-up, only 2.6% and 9.7% had ambulatory ECG monitoring in the 7 days and 12 months post-stroke,

34 ved 25 minutes per week of continuous Holter ECG monitoring, including 5 minutes of rest, 5 minutes o

35 r acute cardiac ischemia, continuous 12-lead ECG monitoring increases the detection of diagnostic ECG

36 Although continuous electrocardiographic (ECG) monitoring is ubiquitous in hospitals, monitoring p

37 e dobutamine echocardiography and ambulatory ECG monitoring may also have a role.

38 During ambulatory ECG monitoring, mean number of ischemic episodes per 48

39 item online test, quality of care related to ECG monitoring (N=4587 patients) by on-site observation,

40 arrhythmic effects as assessed by continuous ECG monitoring of patients in the first week after admis

41 can Heart Association practice standards for ECG monitoring on nurses' knowledge, quality of care, an

42 Continuous 12-lead ECG monitoring provides an accurate characterization of

43 The electrocardiogram (ECG) monitoring provides a noninvasive, real-time physio

44 Furthermore, ambulatory ECG monitoring reveals prolonged QT(c) intervals, reflec

45 atively, 7 of 7 animals subjected to 24-hour ECG monitoring showed multiple ventricular premature dep

46 Ambulatory ECG monitoring showed no difference in cardiac conductio

47 Aggressive ECG monitoring strategies looking for conduction system

48 idates for TAVR underwent 24-hour continuous ECG monitoring the day before the procedure.

49 Continuous ECG monitoring to detect ischemia after ACS may help to

50 ns were studied by transesophageal pacing or ECG monitoring to determine the mechanism of tachycardia

51 ial fibrillation during at least 24 hours of ECG monitoring underwent randomization within 90 days af

52 Myocardial ischemia during 48-hour ECG monitoring was defined as horizontal or downsloping

53 ad ambulatory (Holter) electrocardiographic (ECG) monitoring was performed from 3 hours preinjection

54 During Holter ECG-monitoring we observed repeated prolonged episodes o

55 Seattle Angina Questionnaire, and ambulatory ECG monitoring were used to assess responses at baseline

56 e ventriculography and electrocardiographic (ECG) monitoring were performed during the mental stress

57 ECG monitoring with an ICM was superior to conventional

58 to undergo additional noninvasive ambulatory ECG monitoring with either a 30-day event-triggered reco

59 ly underwent long-term electrocardiographic (ECG) monitoring with an implantable loop recorder.

60 48 hours of ambulatory electrocardiographic (ECG) monitoring with concurrent self-report measures of